while in the promptly evolving discipline of cancer therapeutics, understanding the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is critical for acquiring successful treatments. Just about the most promising ways is the usage of in vitro bystander outcome assays, which Participate in a pivotal part in enhancing therapeutic efficacy. Thes